Start Date: 06/11/2015

End Date: 09/11/2015

Cost: tbc

Venue: Wellcome Trust Genome Campus, Hinxton, UK


Wellcome Trust Scientific Conferences

Contact Details:

Wellcome Trust Advanced Courses and Scientific Conferences
Wellcome Trust Genome Campus
Hinxton, Cambridge
CB10 1RQ, UK



The 5th Wellcome Trust Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving area. Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale, breadth and availability of epigenomic reference data. In addition, novel developments such as single cell analysis and gene editing present exciting new opportunities. Associations between epigenetic variation, a variety of risk factors and the development of many diseases continue to emerge but causality has, in many instances, not yet been established. This meeting will focus on epigenomic studies across of a wide range of common and other diseases, including approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease. We welcome abstracts from all areas relevant to epigenetic and epigenomic research. Several oral presentations will be chosen from the abstracts submitted. Topics will include: Epigenomics of disease Chromatin organisation Model systems: animal and cellular models Population epigenetics Clinical epigenetics Single cell epigenetics Epigenetic engineering Informatics and technology Scientific programme committee: Stephan Beck, University College London, UK Susan Clark, The Garvan Institute of Medical Research, Australia Andy Feinberg, Johns Hopkins University School of Medicine, USA Edith Heard, Institut Curie, France Caroline Relton, University of Bristol, UK For further information, visit: